| Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. | |
| | |
MedLine Citation:
|
PMID: 14530859 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To investigate the acute effects of intravenous sildenafil on haemodynamics and oxygenation, and its interaction with inhaled nitric oxide (iNO) in infants at risk of pulmonary hypertension early after cardiac surgery. DESIGN: Prospective, randomised trial. SETTING: Paediatric intensive care unit of a children's hospital. PATIENTS AND PARTICIPANTS: Sixteen ventilated infants early after closure of ventricular or atrioventricular septal defects, were randomly assigned to one of two groups. The study was completed in 15 infants. INTERVENTIONS: Studies were commenced within 7 h of separation from bypass. Seven infants received iNO (20 ppm) first, with the addition of intravenous sildenafil (0.35 mg/kg over 20 min) after 20 min. Eight infants received sildenafil first, iNO was added after 20 min. Vascular pressures, cardiac output and a blood gas were recorded at 0, 20 and 40 min. MEASUREMENTS AND RESULTS: In infants receiving iNO first, iNO lowered the pulmonary vascular resistance index (PVRI) from 3.45 to 2.95 units (p=0.01); sildenafil further reduced PVRI to 2.45 units p<0.05). In those receiving sildenafil first, PVRI was reduced from 2.84 to 2.35 units (p<0.05) with sildenafil, and fell to 2.15 units (p=0.01) with the addition of iNO. In both groups, sildenafil reduced the systemic blood pressure and systemic vascular resistance (p<0.01) and worsened arterial oxygenation and the alveolar-arterial gradient (p<0.05). CONCLUSION: Intravenous sildenafil augmented the pulmonary vasodilator effects of iNO in infants early after cardiac surgery. However, sildenafil produced systemic hypotension and impaired oxygenation, which was not improved by iNO. |
| | |
Authors:
|
Christian Stocker; Daniel J Penny; Christian P Brizard; Andrew D Cochrane; Rodrigo Soto; Lara S Shekerdemian |
Related Documents
:
|
1463169 - Mortality prediction in infants with congenital diaphragmatic hernia: potential criteri... 8134179 - Oxidant stress responses in premature infants during exposure to hyperoxia. 9797629 - Arterial oxygen saturation profiles in healthy preterm infants. 2313179 - Detection of extrinsic bronchial compression during foreign body removal by pulse oxime... 19776649 - Impact of oxygen saturation targets and oxygen therapy during the transport of neonates... 7952669 - A feedback controller for supplemental oxygen treatment of newborn infants: a simulatio... 10835059 - Pulmonary outcome in extremely low birth weight infants. 11521039 - Limited hip abduction in the infant. 9071249 - Urine samples from disposable diapers: an accurate method for urine cultures. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't Date: 2003-10-07 |
Journal Detail:
|
Title: Intensive care medicine Volume: 29 ISSN: 0342-4642 ISO Abbreviation: Intensive Care Med Publication Date: 2003 Nov |
Date Detail:
|
Created Date: 2003-11-10 Completed Date: 2004-02-13 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7704851 Medline TA: Intensive Care Med Country: United States |
Other Details:
|
Languages: eng Pagination: 1996-2003 Citation Subset: IM |
Affiliation:
|
Department of Intensive Care, Royal Children's Hospital, Flemington Road, 3052, Parkville, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Inhalation Blood Pressure / drug effects Bronchodilator Agents / pharmacology, therapeutic use* Cardiac Output / drug effects Drug Synergism Drug Therapy, Combination Female Heart Septal Defects, Atrial / surgery Heart Septal Defects, Ventricular / surgery Humans Hypertension, Pulmonary / etiology, prevention & control* Infant Infant, Newborn Infusions, Intravenous Male Nitric Oxide / pharmacology, therapeutic use* Piperazines / pharmacology, therapeutic use* Postoperative Complications / etiology, prevention & control* Prospective Studies Pulmonary Circulation / drug effects Purines Risk Factors Sulfones Treatment Outcome Vascular Resistance / drug effects Vasodilator Agents / pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Bronchodilator Agents; 0/Piperazines; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 139755-83-2/sildenafil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intra-abdominal pressure may be decreased non-invasively by continuous negative extra-abdominal pres...
Next Document: Measurement of lung volume in mechanically ventilated monkeys with an ultrasonic flow meter and the ...